The FDAs move, the OFA contends, deprives patients of a vital treatment for type 2 diabetes, obesity, cardiovascular disease, and other serious medical conditions. The trade group is asking the court to declare the FDAs action unlawful, vacate the declaration and prevent the regulator from taking action against any of the Associations members for compounding semaglutide
A quick search on social media using hashtags like #reta or #retatrutide pulls up countless posts from people touting benefits like rapid fat loss, more energy, improved mood, and better overall health
However, as noted by Mahiques-Santos, while melanotan II has been investigated as a potential ED treatment, it has been largely superseded by a nasally administered molecule (PT-141, Palatin Technologies), an active metabolite of the molecule [1]
These meds dont prevent pregnancythey just help regulate insulin and appetite
Limited human pharmacokinetic data confirms GH elevation
At equivalent diabetes doses, the two medications produce very similar GI side effect rates